BioClinica and SYNARC - One Mission. One Company.

BioClinica and SYNARC have merged to create the world's foremost medical imaging and cardiovascular core lab with unrivalled scientific and operational capabilities for advancing clinical trials. Together, our company now offers the industry's most comprehensive clinical imaging program to support all pharmaceutical, biotechnology, and device companies in their efforts to develop next generation treatments across major therapeutic areas.

The new BioClinica will combine the talent and the best practices of both companies, providing a broader and more diversified suite of clinical trial services, greater scientific expertise and increased operational scale to our clients. Our combination of world class scientific expertise, deep clinical trial experience and innovative technologies are proven to reduce clinical trial costs, shorten drug development time, and improve data quality and regulatory compliance.